Base and Prime Editing in the Retina—From Preclinical Research toward Human Clinical Trials
Inherited retinal diseases (IRDs) are a clinically and genetically heterogeneous group of diseases that are one of the leading causes of vision loss in young and aged individuals. IRDs are mainly caused by a loss of the post-mitotic photoreceptor neurons of the retina, or by the degeneration of the...
Main Authors: | Tiffany Yee, Katherine J. Wert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/20/12375 |
Similar Items
-
In Vivo Applications of CRISPR-Based Genome Editing in the Retina
by: Wenhan Yu, et al.
Published: (2018-05-01) -
Prime Editing for Inherited Retinal Diseases
by: Bruna Lopes da Costa, et al.
Published: (2021-11-01) -
Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances
by: Michelle E. McClements, et al.
Published: (2020-11-01) -
Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations
by: Ahmed Salman, et al.
Published: (2022-09-01) -
Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases
by: Silja Hansen, et al.
Published: (2023-01-01)